Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive factors for the development of brain metastases in patients with malignant melanoma: a study by the Anatolian society of medical oncology.
Gumusay O, Coskun U, Akman T, Ekinci AS, Kocar M, Erceleb OB, Yazıcı O, Kaplan MA, Berk V, Cetin B, Taskoylu BY, Yildiz A, Goksel G, Alacacioglu A, Demirci U, Algin E, Uysal M, Oztop I, Oksuzoglu B, Dane F, Gumus M, Buyukberber S. Gumusay O, et al. Among authors: ekinci as. J Cancer Res Clin Oncol. 2014 Jan;140(1):151-7. doi: 10.1007/s00432-013-1553-7. Epub 2013 Nov 29. J Cancer Res Clin Oncol. 2014. PMID: 24292400
Comparison the efficacy of second-line modified EOX (epirubicin, oxaliplatin, and capecitabine) and irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) regimens in metastatic gastric cancer patients that progressed on first-line modified docetaxel and cisplatin plus fluorouracil (DCF) regimen.
Sendur MA, Ozdemir N, Özatlı T, Yazıcı O, Aksoy S, Ekinci AS, Yazılıtaş D, Günaydın Y, Oksuzoglu B, Benekli M, Zengin N. Sendur MA, et al. Among authors: ekinci as. Med Oncol. 2014 Sep;31(9):153. doi: 10.1007/s12032-014-0153-y. Epub 2014 Aug 7. Med Oncol. 2014. PMID: 25099765
Is second-line systemic chemotherapy beneficial in patients with non-small cell lung cancer (NSCLC)? A multicenter data evaluation by the Anatolian Society of Medical Oncology.
Odabas H, Ulas A, Aydin K, Inanc M, Aksoy A, Yazilitas D, Turkeli M, Yuksel S, Inal A, Ekinci AS, Sevinc A, Demirci NS, Uysal M, Alkis N, Dane F, Aliustaoglu M, Gumus M. Odabas H, et al. Among authors: ekinci as. Tumour Biol. 2015 Dec;36(12):9641-8. doi: 10.1007/s13277-015-3728-0. Epub 2015 Jul 7. Tumour Biol. 2015. PMID: 26150339
Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma.
Turan N, Benekli M, Unal OU, Unek İT, Tastekin D, Dane F, Algın E, Ulger S, Eren T, Topcu TO, Turkmen E, Babacan NA, Tufan G, Urakci Z, Ustaalioglu BO, Uysal OS, Ercelep OB, Taskoylu BY, Aksoy A, Canhoroz M, Demirci U, Dogan E, Berk V, Balakan O, Ekinci AŞ, Uysal M, Petekkaya İ, Ozturk SC, Tonyalı Ö, Çetin B, Aldemir MN, Helvacı K, Ozdemir N, Oztop İ, Coskun U, Uner A, Ozet A, Buyukberber S; Anatolian Society of Medical Oncology (ASMO). Turan N, et al. Among authors: ekinci as. Chin J Cancer Res. 2015 Aug;27(4):408-16. doi: 10.3978/j.issn.1000-9604.2015.08.03. Chin J Cancer Res. 2015. PMID: 26361410 Free PMC article.
Sunitinib-induced severe hypoglycemia in a diabetic patient.
Demirci A, Bal O, Durnali A, Ekinci AŞ, Eşbah O, Alkiş N, Oksüzoğlu B. Demirci A, et al. Among authors: ekinci as. J Oncol Pharm Pract. 2014 Dec;20(6):469-72. doi: 10.1177/1078155213508441. Epub 2013 Oct 24. J Oncol Pharm Pract. 2014. PMID: 24158980
Prognostic Factors in Operated Stage IIIC, Pathological N3a Breast Cancer Patients.
Turker I, Arslan UY, Yazici O, Uyeturk U, Oksuzoglu B, Budakoglu B, Özdemir N, Sonmez OU, Helvaci K, Esbah O, Bal O, Ekinci AS, Zengin N. Turker I, et al. Among authors: ekinci as. Breast Care (Basel). 2014 Dec;9(6):421-7. doi: 10.1159/000366438. Breast Care (Basel). 2014. PMID: 25759625 Free PMC article.
21 results